Keyphrases
AKT/mammalian Target of Rapamycin
80%
Inhibits Proliferation
80%
Colorectal Cancer
54%
Phosphoinositide 3-kinase (PI3K)
45%
Mammalian Target of Rapamycin Signaling Pathway
40%
AKT2
40%
NFATc1
40%
Triptolide
40%
Virgin Abdomen
40%
AKT1
40%
Histone Deacetylase Inhibitor (HDACi)
40%
Cytokine Receptor
40%
Curcumin
40%
Nuclear Factor of Activated T Cells
40%
Translational Research
40%
Nonoperative Management
40%
T Cell Signaling
40%
Human Colorectal Cancer
40%
PTEN Expression
40%
Colorectal Carcinoma
40%
Expression Pattern
40%
Neurotensin Receptor
40%
Water Use
40%
Water-soluble Contrast
40%
Colon Cancer Cells
40%
Intestinal Obstruction
40%
Gastric Cancer
40%
Gastric Malignancy
40%
Cell Cycle Regulators
40%
Receptor Subtypes
40%
Intestinal Cell Differentiation
40%
Immunology
40%
Mammalian Target of Rapamycin Signaling
40%
NTR1
40%
Epigenetic Modification
40%
Glycogen Synthase Kinase 3 (GSK3)
30%
NFATc4
28%
Tyrosine Kinase
20%
Histone Acetylation
20%
DNA Hypermethylation
20%
Helicobacter Pylori Eradication
20%
Expression Level
20%
Gastrointestinal Hormones
20%
Prognostic Implications
20%
Clinical Trials
20%
Drug Target
20%
Oncogene
20%
Colon Tissue
20%
Helicobacter Pylori Infection
20%
Host Genetics
20%
Medicine and Dentistry
Cancer
100%
Colorectal Carcinoma
80%
Cancer Cell
45%
Patient History of Surgery
40%
Triptolide
40%
Translational Research
40%
Small Intestine Obstruction
40%
Phosphoinositide 3-Kinase
40%
Cytokine Receptor
40%
Histone Deacetylase Inhibitor
40%
Glycogen Synthase Kinase
40%
Cell Cycle
40%
Neurotensin Receptor
40%
Akt/mTOR Signaling
40%
Abdominal Cancer
40%
Colon Carcinoma
40%
Protein Kinase B Beta
40%
Immunology
26%
Mitogen-Activated Protein Kinase
25%
Adhesive Agent
20%
Digestive System Surgery
20%
Case Presentation
20%
Surgical Exploration
20%
Pelvis
20%
Recurrent Disease
20%
Abdominal Pain
20%
Meta-Analysis
20%
Prevalence
20%
Mechanistic Target of Rapamycin
20%
Colon
20%
Treatment Option
20%
Therapeutic Use
20%
Protein Kinase B
20%
Promoter Region
15%
Messenger RNA
14%
Protein Tyrosine Kinase
13%
Helicobacter Infection
13%
Clinical Trial
13%
Growth Factor
13%
Proto Oncogene
13%
Gastrointestinal Polypeptide
13%
Drug Delivery System
13%
DNA Methylation
13%
Histone
13%
Cancer Prognosis
13%
Cancer Research
13%
Deacetylation
13%
Colon Tissue
10%
Mitogen Activated Protein Kinase 6
10%
Colon Mucosa
10%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
80%
Mammalian Target of Rapamycin
40%
Patient History of Surgery
40%
Phosphatidylinositol 3 Kinase
40%
Triptolide
40%
Small Intestine Obstruction
40%
Cytokine Receptor
40%
Neurotensin Receptor
40%
Glycogen Synthase Kinase
40%
Histone Deacetylase Inhibitor
40%
Colon Carcinoma
40%
Abdominal Cancer
40%
Protein Kinase B Beta
40%
Mitogen Activated Protein Kinase
25%
Therapeutic Use
20%
Prevalence
20%
Recurrent Disease
20%
Adhesive Agent
20%
Abdominal Pain
20%
Messenger RNA
14%
Histone
13%
Helicobacter Infection
13%
Cancer Prognosis
13%
Growth Factor
13%
Drug Delivery System
13%
Protein Tyrosine Kinase
13%
Clinical Trial
13%
Gastrointestinal Polypeptide
13%
Cancer Staging
10%
Mitogen Activated Protein Kinase 6
10%
Neurotensin
10%
Phosphotransferase
10%
Malignant Neoplasm
8%
Cancer Growth
8%
Vasculotropin
8%
Cyclooxygenase 2
5%
Growth Disorder
5%
Interleukin 8
5%
Butyrate
5%
Phosphotransferase Inhibitor
5%
